The current kidney care model—focused on late-stage disease and in-center hemodialysis—is unsustainable, because of costs, environmental burden, poor outcomes, and reduced quality of life.

Actor and model Bijou Phillips revealed she’s in dire need of a kidney transplant ― and is “hanging on by a thread.” “I could ...

Mayo Clinic researchers have identified a drug-and-supplement combination therapy that is capable of reducing the harmful effects of senescent cells—also known as "zombie cells"—in diabetic kidney ...

"The chronic kidney failure has taken six lives from my family, including my father, brothers, and sister. It has shattered ...

Many people reach for ibuprofen when they have a headache, sore muscles, or joint pain. It is one of the most widely used ...

Mayo Clinic researchers have identified a drug-and-supplement combination therapy that is capable of reducing the harmful effects of senescent cells – also known as "zombie cells" – in diabetic kidney ...

DaVita Inc. DVA has been gaining from its business model. The optimism, led by a solid fourth-quarter 2025 performance and the overseas growth, is expected to contribute further. However, concerns ...

Experts warn that recurrent kidney stones and declining kidney function may signal a curable hormone disorder. TAMPA, ...

The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).

Bijou Phillips is opening up about her “urgent” health crisis as she continues a desperate search for a life-saving kidney donor. The 45-year-old model and socialite, who is currently receiving ...

Diabetic kidney disease is one of the most serious complications of diabetes. It affects millions of people around the world and is the leading cause of kidney failure in many countries. In the United ...

DaVita (NYSE:DVA) is responding to declines in dialysis patient volumes by adjusting its clinical and business priorities. The company is focusing on higher vaccination rates and newer therapies as ...